Foster & Motley Inc. lessened its position in shares of AmerisourceBergen Corp. (NYSE:ABC) by 4.2% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,034 shares of the company’s stock after selling 223 shares during the quarter. Foster & Motley Inc.’s holdings in AmerisourceBergen were worth $400,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. TIAA CREF Investment Management LLC lifted its stake in shares of AmerisourceBergen by 9.1% in the 3rd quarter. TIAA CREF Investment Management LLC now owns 1,092,988 shares of the company’s stock valued at $100,795,000 after purchasing an additional 91,364 shares during the period. Legal & General Group Plc lifted its stake in shares of AmerisourceBergen by 1.2% in the 3rd quarter. Legal & General Group Plc now owns 862,025 shares of the company’s stock valued at $79,496,000 after purchasing an additional 10,077 shares during the period. Vanguard Group Inc lifted its stake in shares of AmerisourceBergen by 0.4% in the 3rd quarter. Vanguard Group Inc now owns 16,019,657 shares of the company’s stock valued at $1,477,332,000 after purchasing an additional 63,935 shares during the period. Steward Partners Investment Advisory LLC lifted its stake in shares of AmerisourceBergen by 12.0% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 6,138 shares of the company’s stock valued at $456,000 after purchasing an additional 657 shares during the period. Finally, Bell Asset Management Ltd lifted its stake in shares of AmerisourceBergen by 14.1% in the 4th quarter. Bell Asset Management Ltd now owns 121,331 shares of the company’s stock valued at $9,027,000 after purchasing an additional 14,993 shares during the period. 66.73% of the stock is currently owned by hedge funds and other institutional investors.

A number of research analysts have recently commented on the company. ValuEngine upgraded AmerisourceBergen from a “strong sell” rating to a “sell” rating in a research note on Friday, May 3rd. Zacks Investment Research cut AmerisourceBergen from a “hold” rating to a “sell” rating in a research note on Thursday, March 14th. Wolfe Research assumed coverage on AmerisourceBergen in a research note on Tuesday, April 2nd. They issued a “market perform” rating for the company. TheStreet cut AmerisourceBergen from a “b” rating to a “c+” rating in a research note on Tuesday, March 19th. Finally, Guggenheim assumed coverage on AmerisourceBergen in a research note on Thursday, April 11th. They issued a “buy” rating for the company. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $86.38.

In other AmerisourceBergen news, CEO Steven H. Collis sold 21,344 shares of AmerisourceBergen stock in a transaction on Friday, March 1st. The stock was sold at an average price of $83.62, for a total transaction of $1,784,785.28. Following the completion of the transaction, the chief executive officer now owns 155,923 shares in the company, valued at $13,038,281.26. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Dale Danilewitz sold 5,702 shares of AmerisourceBergen stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $77.61, for a total value of $442,532.22. Following the transaction, the insider now owns 7,330 shares of the company’s stock, valued at approximately $568,881.30. The disclosure for this sale can be found here. In the last quarter, insiders have acquired 2,018 shares of company stock valued at $156,471 and have sold 40,086 shares valued at $3,235,648. 27.80% of the stock is currently owned by insiders.

ABC opened at $80.57 on Wednesday. The company has a market capitalization of $16.85 billion, a PE ratio of 12.41, a PEG ratio of 1.51 and a beta of 1.07. AmerisourceBergen Corp. has a 52 week low of $69.36 and a 52 week high of $94.88. The company has a debt-to-equity ratio of 1.43, a current ratio of 0.95 and a quick ratio of 0.56.

AmerisourceBergen (NYSE:ABC) last announced its quarterly earnings data on Thursday, May 2nd. The company reported $2.11 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.96 by $0.15. The business had revenue of $43.32 billion during the quarter, compared to analysts’ expectations of $43.44 billion. AmerisourceBergen had a return on equity of 46.24% and a net margin of 0.53%. The firm’s quarterly revenue was up 5.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.94 earnings per share. As a group, research analysts expect that AmerisourceBergen Corp. will post 6.81 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 3rd. Shareholders of record on Monday, May 20th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.99%. The ex-dividend date is Friday, May 17th. AmerisourceBergen’s payout ratio is 24.65%.

COPYRIGHT VIOLATION WARNING: This piece was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://theolympiareport.com/2019/05/22/foster-motley-inc-has-400000-stake-in-amerisourcebergen-corp-abc.html.

About AmerisourceBergen

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.

Read More: How to Trade Using Analysts Ratings

Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).

Institutional Ownership by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.